Additional SNVs control ERAP2 expression by mechanisms other than alternative splicing, and variants linked to autoimmune diseases also alter enhancer-promoter interactions of ERAP2 leading to increased expression levels [20]. The gene discussed is ERAP2; the disease is autoimmune disease.